Investor Update

Basel, 23 May 2019

Reminder: Invitation to Roche Analyst Event at ASCO 2019 - Monday, 3 June 2019

We are pleased to invite you to an analyst briefing to discuss data presented on the Roche Group's oncology products and pipeline at the American Society of Clinical Oncology Annual Meeting (ASCO) in Chicago (31 May - 4 June 2019).

Date/Time (CDT)

Monday, 3 June 2019

5:30pm Registration desk opens

6:00pm Start of meeting

7:15pm End of meeting followed by a buffet reception


Marriott Downtown Chicago

540 North Michigan Avenue

60611 Chicago



  • Welcome
    Karl Mahler, Head of Investor Relations
  • ASCO 2019 Key readouts across tumor types
    Nancy Valente, M.D., Global Head of Product Development - Hematology

    Breast cancer, lung cancer & pan-tumor
    Alan Sandler, M.D., Global Head of Product Development - Solid Tumors
  • Roche Oncology strategy update
    Bill Anderson, CEO Roche Pharmaceuticals
  • Q&A

To register for the event, please follow the link (Password: Analyst2019).

A live video webcast can be accessed via The presentation slides will be available from the IR website at following the closure of the ASCO meeting.

A replay of the webcast will be available on demand on the Roche website. click here.

In order to receive your personal dial-in details and expedite your access to the conference call, please pre-register under this link.

If you have not pre-registered, please find the dial-in numbers below, we recommend you to dial in to the conference 10-15 min prior to the scheduled start.

+41 (0) 58 310 5000 (Europe and ROW)
+44 (0) 207 107 0613 (UK)
+1 (1) 631 570 5613 (USA Toll Free)

In addition, we have prepared an ASCO planner providing an overview of oral and poster abstracts relevant to Roche, including indication of time and venue of the respective presentations at the congress. This planner can be downloaded from our website. click here